{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:52:55Z","timestamp":1785268375813,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1136\/ard.60.5.487","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:45:32Z","timestamp":1027766732000},"page":"487-494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma)"],"prefix":"10.1016","volume":"60","author":[{"given":"M","family":"Matucci-Cerinic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pignone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M L","family":"Cagnoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Generini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Casale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Del Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Tirassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y T","family":"Konttinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B M","family":"Kahaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P-S","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Marchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Cagnoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Aloe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.60.5.487_bib1","series-title":"Systemic sclerosis.","first-page":"513","article-title":"The vascular involvement in systemic sclerosis.","author":"Matucci Cerinic","year":"1995"},{"key":"10.1136\/ard.60.5.487_bib2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00002281-199811000-00011","article-title":"Biology of the scleroderma fibroblast.","volume":"10","author":"Strelhow","year":"1998","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard.60.5.487_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0738-081X(94)90287-9","article-title":"Immune abnormalities in systemic sclerosis.","volume":"12","author":"White","year":"1994","journal-title":"Clin Dermatol"},{"key":"10.1136\/ard.60.5.487_bib4","series-title":"Oxford textbook of rheumatology.","first-page":"771","article-title":"Systemic sclerosis (scleroderma).","author":"Black","year":"1993"},{"key":"10.1136\/ard.60.5.487_bib5","first-page":"601","article-title":"Peripheral neuropathy in systemic sclerosis. The median nerve as a target structure.","volume":"14","author":"Lori","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.60.5.487_bib6","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0889-857X(05)70306-9","article-title":"The nervous system in systemic sclerosis (scleroderma): clinical and pathogenetic features.","volume":"22","author":"Matucci Cerinic","year":"1996","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1136\/ard.60.5.487_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.1780380102","article-title":"Raynaud's phenomenon and scleroderma: dysregulated neuroendothelial control of vascular tone.","volume":"38","author":"Kahaleh","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.5.487_bib8","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0166-2236(96)10058-8","article-title":"Nerve growth factor: from neurotrophin to neurokine.","volume":"19","author":"Levi-Montalcini","year":"1997","journal-title":"Trends Neurosci"},{"key":"10.1136\/ard.60.5.487_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.ne.03.030180.002033","article-title":"The nerve growth factor: biochemistry, synthesis, and mechanism of action.","volume":"3","author":"Greene","year":"1980","journal-title":"Ann Rev Neurosci"},{"key":"10.1136\/ard.60.5.487_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0006-8993(82)90969-6","article-title":"Regulation of substance P by NGF: disruption by capsaicin.","volume":"250","author":"Miller","year":"1987","journal-title":"Brain Res"},{"key":"10.1136\/ard.60.5.487_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0006-291X(92)91203-3","article-title":"Human fibroblast cells synthesize and secrete nerve growth factor.","volume":"184","author":"Murase","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1136\/ard.60.5.487_bib12","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1073\/pnas.91.9.3739","article-title":"Mast cells synthesize, store and release nerve growth factor.","volume":"91","author":"Leon","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.60.5.487_bib13","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.4049\/jimmunol.153.10.4488","article-title":"NGF production by lymphocytes.","volume":"153","author":"Santambrogio","year":"1994","journal-title":"J Immunol"},{"key":"10.1136\/ard.60.5.487_bib14","doi-asserted-by":"crossref","first-page":"21718","DOI":"10.1016\/S0021-9258(18)54695-0","article-title":"Growth regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes.","volume":"266","author":"Di Marco","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.60.5.487_bib15","first-page":"433","article-title":"Nerve growth factor and autoimmune rheumatic diseases.","volume":"15","author":"Aloe","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.60.5.487_bib16","first-page":"1798","article-title":"Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levels.","volume":"23","author":"Falcini","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.5.487_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08916939608995352","article-title":"Nerve growth factor autoantibodies and NGF in the synovial fluid: implications in spondyloarthropathies.","volume":"24","author":"Dicou","year":"1996","journal-title":"Autoimmunity"},{"key":"10.1136\/ard.60.5.487_bib18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/ard.55.10.745","article-title":"Circulating NGF is directly correlated with disease activity in juvenile chronic arthritis.","volume":"55","author":"Falcini","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.60.5.487_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/08916939409009542","article-title":"NGF and autoimmune diseases.","volume":"19","author":"Aloe","year":"1994","journal-title":"Autoimmunity"},{"key":"10.1136\/ard.60.5.487_bib20","first-page":"319","article-title":"Nerve growth factor and mast cell distribution in the skin of patients with systemic sclerosis.","volume":"11","author":"Tuveri","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.60.5.487_bib21","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0889-857X(21)00216-7","article-title":"Sensory neuropeptides and rheumatic diseases.","volume":"19","author":"Matucci Cerinic","year":"1993","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1136\/ard.60.5.487_bib22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00002281-199805000-00011","article-title":"Neuropeptides and hormones in arthritis.","volume":"10","author":"Matucci Cerinic","year":"1998","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard.60.5.487_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1096-9861(19980406)393:2<231::AID-CNE7>3.0.CO;2-3","article-title":"Overexpression of NGF in epidermis disrupts the distribution and properties of sympathetic innervation in footpads.","volume":"393","author":"Guidry","year":"1998","journal-title":"J Comp Neurol"},{"key":"10.1136\/ard.60.5.487_bib24","first-page":"102","article-title":"Substance P and vasoactive intestinal peptide in patients with progressive scleroderma. Determination of plasma level before and after autogenic training.","volume":"46","author":"Hautstein","year":"1995","journal-title":"Hautartz"},{"key":"10.1136\/ard.60.5.487_bib25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/03009749950155616","article-title":"Plasma noradrenaline and neuropeptide Y may not be of primary importance in the pathophysiology of cardiac involvement in systemic sclerosis.","volume":"28","author":"Kazzam","year":"1999","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.60.5.487_bib26","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.5.487_bib27","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/j.1471-4159.1987.tb05736.x","article-title":"An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues.","volume":"48","author":"Weskamp","year":"1987","journal-title":"J Neurochem"},{"key":"10.1136\/ard.60.5.487_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0304-3940(92)90762-V","article-title":"Multiple sclerosis patients express increased levels of b-nerve growth factor in cerebrospinal fluid.","volume":"147","author":"Bracci-Laudiero","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.1136\/ard.60.5.487_bib29","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/sj.bjp.0701718","article-title":"Cholecystokinin-8 regulates NGF concentrations in adult mouse brain through a mechanism involving CCKA and CCKB receptors.","volume":"123","author":"Tirassa","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1136\/ard.60.5.487_bib30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1073\/pnas.64.2.787","article-title":"The nerve growth factor: purification as a 30,000-molecular-weight protein.","volume":"64","author":"Bocchini","year":"1969","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.60.5.487_bib31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/ard.56.12.737","article-title":"Neuropeptides of the autonomic nervous system in Sj\u00f6gren syndrome.","volume":"56","author":"Santavirta","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.60.5.487_bib32","first-page":"572","article-title":"Antiendothelial cell antibodies in systemic sclerosis: correlation with vascular involvement.","volume":"16","author":"Pignone","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.60.5.487_bib33","first-page":"367","article-title":"A modified scleroderma skin scoring method.","volume":"4","author":"Kahaleh","year":"1986","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.60.5.487_bib34","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/rheumatology\/34.9.831","article-title":"Arthritis in scleroderma.","volume":"34","author":"Misra","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.60.5.487_bib35","first-page":"428","article-title":"Angiotensin converting enzyme: an in vivo and in vitro marker of endothelial injury.","volume":"120","author":"Matucci Cerinic","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1136\/ard.60.5.487_bib36","series-title":"Statistics and data mining: interacting disciplines. Vol 1.","first-page":"16","author":"Hand","year":"1999"},{"key":"10.1136\/ard.60.5.487_bib37","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1006\/bbrc.1996.0325","article-title":"Beta-NGF as a mediator of the acute phase response in vivo.","volume":"219","author":"Nonogaki","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1136\/ard.60.5.487_bib38","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0306-4522(96)00575-1","article-title":"The role of nerve growth factor in a model of visceral inflammation.","volume":"78","author":"Dmitrieva","year":"1997","journal-title":"Neuroscience"},{"key":"10.1136\/ard.60.5.487_bib39","doi-asserted-by":"crossref","first-page":"7215","DOI":"10.1073\/pnas.80.23.7215","article-title":"Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis.","volume":"80","author":"Gee","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.60.5.487_bib40","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0091-6749(98)70135-6","article-title":"Nerve growth factor is performed in and activates human peripheral blood eosinophils.","volume":"102","author":"Solomon","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1136\/ard.60.5.487_bib41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4049\/jimmunol.157.1.313","article-title":"Nerve growth factor and cytokines mediate lymphoid tissue-induced neurite outgrowth from mouse superior cervical ganglia in vitro.","volume":"157","author":"Kannan","year":"1996","journal-title":"J Immunol"},{"key":"10.1136\/ard.60.5.487_bib42","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1476-5381.1995.tb15035.x","article-title":"Contribution of IL-1 beta to the inflammation-induced increase in NGF levels and inflammatory hyperalgesia.","volume":"115","author":"Safieh-Garabedian","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1136\/ard.60.5.487_bib43","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1098\/rstb.1996.0040","article-title":"Phenotypic modification of primary sensory neurons: role of nerve growth factor in the production of persistent pain.","volume":"351","author":"Woolf","year":"1996","journal-title":"Philos Trans R Soc London B Biol Sci"},{"key":"10.1136\/ard.60.5.487_bib44","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.4049\/jimmunol.157.12.5582","article-title":"Basophil priming by neurotrophic factors. Activation through the trk receptors.","volume":"157","author":"Burgi","year":"1996","journal-title":"J Immunol"},{"key":"10.1136\/ard.60.5.487_bib45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0306-4522(94)90366-2","article-title":"Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity.","volume":"64","author":"Woolf","year":"1994","journal-title":"Neuroscience"},{"key":"10.1136\/ard.60.5.487_bib46","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3109\/00365528708991971","article-title":"Successful treatment of esophageal dismotility and Raynaud's phenomenon in systemic sclerosis and achalasia by transcutaneous nerve stimulation. Increase in plasma VIP concentration.","volume":"22","author":"Kaada","year":"1987","journal-title":"Scand J Gastroenterol"},{"key":"10.1136\/ard.60.5.487_bib47","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/exnr.1997.6515","article-title":"The antioxidant enzymes glutathione peroxidase and catalase increase following traumatic brain injury in the rat.","volume":"146","author":"Goss","year":"1997","journal-title":"Exp Neurol"},{"key":"10.1136\/ard.60.5.487_bib48","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/j.1471-4159.1993.tb09808.x","article-title":"Role of NGF in oxidant homeostasis: glutathione metabolism.","volume":"61","author":"Pan","year":"1993","journal-title":"J Neurochem"},{"key":"10.1136\/ard.60.5.487_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0006-8993(96)00844-X","article-title":"Increased uptake of L-cysteine and L-cystine by NGF in rat pheocromocytoma cells.","volume":"740","author":"Pan","year":"1996","journal-title":"Brain Res"},{"key":"10.1136\/ard.60.5.487_bib50","first-page":"559","article-title":"Regulation of gamma-glutamylcysteine synthetase activity by nerve growth factor.","volume":"14","author":"Pan","year":"1996","journal-title":"Int J Dev Neurosci"},{"key":"10.1136\/ard.60.5.487_bib51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/01.CIR.95.1.213","article-title":"Protective role of nerve growth factor against postischemic dysfunction of sympathetic coronary innervation.","volume":"95","author":"Abe","year":"1997","journal-title":"Circulation"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724442623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724442623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.60.5.487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T06:02:45Z","timestamp":1736143365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724442623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["S0003496724442623"],"URL":"https:\/\/doi.org\/10.1136\/ard.60.5.487","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2001,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma)","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.60.5.487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Annals of the Rheumatic Diseases. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}